International Journal of Clinical Oncology

International Journal of Clinical Oncology

INT J CLIN ONCOL
影响因子:2.8
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:JAPAN
出版社:Springer Singapore
发刊时间:1996
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1341-9625

期刊介绍

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
《国际临床肿瘤学杂志》(IJCO)欢迎关于临床肿瘤学各个方面的原创研究论文,这些论文报告了新颖和及时的研究结果。鼓励临床试验报告。如果实验性研究与临床肿瘤学有明显相关性,也将被接受。日本临床肿瘤学会会员资格不是向期刊投稿的先决条件。收到文件时有一项了解:其全部或部分内容未在其他地方发表;至少由两名审稿人和编辑对稿件进行同行评审,并对稿件的语言和内容进行编辑性修改;并且编辑对其接受、拒绝和发布顺序负责。
年发文量 218
国人发稿量 21.52
国人发文占比 0.1%
自引率 -
平均录取率0
平均审稿周期 平均2月
版面费 US$4190
偏重研究方向 医学-肿瘤学
期刊官网 https://www.springer.com/10147
投稿链接 https://www.editorialmanager.com/ijco

期刊高被引文献

Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01497-9
CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01403-3
Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01409-x
A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01511-0
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01418-w
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01597-6
RFA experiences, indications and clinical outcomes
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01423-z
Clinical impact of periodontal disease on postoperative complications in gastrointestinal cancer patients
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01513-y
Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01426-w
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01464-4
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01552-5
Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01502-1
Immune check-point in endometrial cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01437-7
Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01475-1
Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01592-x
The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01484-0
Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01474-2
Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01469-z
Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01424-y
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01518-7
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01546-3
Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01605-9
Robotic-assisted breast-axillo insufflation thyroidectomy (RABIT): a retrospective case series of thyroid carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01568-x
Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01399-w
A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01553-4
Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01481-3
Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01473-3
Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01410-4
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01432-y
Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01446-6
Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01517-8
Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01550-7
PLEKHG5 is a novel prognostic biomarker in glioma patients
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01503-0
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01530-x
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01420-2
Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01590-z
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01563-2
Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01427-9
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01436-8
Fertility in testicular cancer patients: a single-centre study in Turkey
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01534-7
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01557-0
Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01525-8
Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01564-1
Discrimination between breast invasive ductal carcinomas and benign lesions by optimizing quantitative parameters derived from dynamic contrast-enhanced MRI using a semi-automatic method
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01421-1
Clinical results of carbon-ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01505-y
Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01395-0
The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01581-0
Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male population
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01442-w
Management of elderly patients with head and neck carcinoma: analysis of outcomes for radical versus palliative treatment
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01531-w
Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
来源期刊:International Journal of Clinical OncologyDOI:10.1007/s10147-019-01488-w

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
88.07%24.73%-1.41%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
ONCOLOGY 肿瘤学
4区
2023年12月升级版
医学3区
ONCOLOGY 肿瘤学
4区
2022年12月旧的升级版
医学3区
ONCOLOGY 肿瘤学
4区